Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry - Sciria - 2020 - Clinical Cardiology - Wiley Online Library
Guidance for the safe switching of warfarin to direct oral anticoagulants (DOACs) for patients with non-valvular AF and venou
Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry - Sciria - 2020 - Clinical Cardiology - Wiley Online Library
Replacing warfarin with a NOAC in patients on chronic anticoagulation therapy - The Hospitalist
Atrial fibrillation - NICE guidance April 2021 - A4medicine.co.uk
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Stroke Prevention in Atrial Fibrillation (AF) Protect and Perfect – Optimising anticoagulation treatment | NICE
Anticoagulant Comparison Chart
NICE Guideline Template
NICE comments table
Guidance for Switching from Warfarin to Direct-acting Oral Anticoagulants (DOACs) for patients with Non-Valvular - Atrial Fibril
Venous Thromboembolism in Adults: NICE Updates
DOACs for the treatment of VTE and prevention of recurrent VTE - Pulse Today
Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic - Thrombosis Research
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE)
RxNotes - It is important when switching between warfarin and DOACs (direct oral anticoagulation) to maintain adequate anticoagulation. 🇺🇸NOTE FOR USA: The American recommendations for switching from warfarin to rivaroxaban is INR <
OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic | Open Heart
Direct Oral Anticoagulants Form Thrombus Different From Warfarin in a Microchip Flow Chamber System | Scientific Reports
Rivaroxaban: a fully-subsidised oral anticoagulant
Management of Direct Oral Anticoagulants - ppt download
Standard Operating Procedure (SOP) for switching adult patients prescribed Direct Oral Anticoagulants (DOACs) with Non- Valvular
Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin | Journal of the American Heart Association
Cancers | Free Full-Text | Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers
Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week - ScienceDirect
ADAS Anticoagulant Dosing and Advisory Service - ppt download
NG196 Evidence review G1
Warfarin patients switching to DOACs or remaining on warfarin. Number... | Download Scientific Diagram
Management of Non-valvular Atrial Fibrillation
